Komori
Toyo Suisan (2875) · InitiativeAdvanced

Research and Development of High-Quality, Health-Oriented Products

First written in FY2016. 7 of 21 entries say "Advanced", first in FY2017. Latest entry: FY2026.

21entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017 – FY2019OtherFY2020-Q2 – FY2021-Q3OtherFY2023-Q2 – FY2024-Q3AdvancedFY2024 – FY20262016: 120162017: 120172018: 020182019: 220192020: 320202021: 420212022: 320222023: 320232024: 220242025: 120252026: 12026
Same theme, other companies

The whole theme swung hardest in 2022: 1 of 8 companies on the "Worse" side.

3 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「In the overseas instant noodle business, the company expanded its lineup of high-value-added products by launching the new “Spicy Tonkotsu” flavor in the authentic-oriented, non-fried noodle “MARUCHAN GOLD” series. It also launched the new “SAUCY NOODS” brand to attract younger consumers and worked to expand its range of flavors.」

    The company broadened specific R&D product initiatives, including high-value-added products, new brands for younger consumers, and convenient, health-oriented and environmentally considerate products.
  2. FY2025AdvancedAnnual report

    「In the seafood products business, the company additionally launched “Choi Fish Squid, Shrimp and Vegetable Ajillo” and “Choi Fish Hokkaido Salmon Meunière Style,” bringing the lineup to 8 products. It also launched the “FIRE” series as packaged noodles. R&D expenses for the fiscal year were ¥1,776 million.」

    R&D progressed into specific product initiatives, including an 8-product Choi Fish lineup, products made with MSC-certified ingredients, and the overseas FIRE series, alongside health-oriented, convenient and environmentally considerate products.
  3. FY2024AdvancedAnnual report

    「In the frozen foods business, the company relaunched products in the Japanese-style noodle category as health-oriented products, including “Hokkaido Wheat Tama Udon: Zero Salt,” “Soba, Three Servings,” and “Menjozu Coarse-Ground Soba, Two Servings,” all reformulated with zero salt.」

    The company addressed health-conscious demand through product renewals featuring zero-salt formulations. For R&D activities overall, it also disclosed R&D expenses of ¥1,812 million for the fiscal year.
  4. FY2024-Q3Addition of cumulative third-quarter research and development expensesAnnual report

    「Total R&D expenses for the nine months ended the third quarter were ¥1,353 million.」

    The company additionally disclosed R&D expenses of ¥1,353 million for the nine months ended the third quarter.
  5. FY2024-Q2Additional disclosure of actual R&D expenses for the six months ended the second quarter of FY2024Annual report

    「Total research and development expenses for the cumulative consolidated period through the second quarter were ¥903 million.」

    The company additionally disclosed R&D expenses of ¥903 million for the six months ended the second quarter of FY2024.
  6. FY2024-Q1Addition of cumulative first-quarter research and development expensesAnnual report

    「Total R&D expenses for the three months ended the first quarter were ¥453 million.」

    The company additionally disclosed R&D expenses of ¥453 million for the three months ended the first quarter.
  7. FY2023-Q3Addition of cumulative third-quarter research and development expensesAnnual report

    「Total R&D expenses for the nine months ended the third quarter were ¥1,312 million.」

    The company additionally disclosed R&D expenses of ¥1,312 million for the nine months ended the third quarter.
  8. FY2023-Q2Addition of cumulative second-quarter research and development expensesAnnual report

    「Total R&D expenses for the six months ended the second quarter were ¥880 million.」

    The company additionally disclosed R&D expenses of ¥880 million for the six months ended the second quarter.
  9. FY2022AdvancedAnnual report

    「The seafood products business developed seafood products such as salmon flakes, salmon roe and cod roe for convenience stores and supermarkets, as well as food-service products. Under the concept of "魚を手軽に", the company also expanded its ChoiFish brand of retail frozen fish side dishes by launching "さばのレモン焼", "明太ポテト焼" and "赤魚のアクアパッツァ".」

    The company expanded its R&D scope to seafood products, health-oriented and convenient products, and new brands, bringing R&D expenses for the fiscal year to ¥1,815 million.
  10. FY2022-Q3Addition of cumulative third-quarter research and development expensesAnnual report

    「Total research and development expenses for the cumulative consolidated period through the third quarter were ¥1,349 million.」

    The company additionally disclosed research and development expenses of ¥1,349 million for the cumulative consolidated period through the third quarter.
  11. FY2022-Q2Addition of cumulative second-quarter research and development expensesAnnual report

    「Total research and development expenses for the cumulative consolidated period through the second quarter were ¥903 million.」

    The company additionally disclosed research and development expenses of ¥903 million for the cumulative consolidated period through the second quarter.
  12. FY2022-Q1Addition of cumulative first-quarter research and development expensesAnnual report

    「Total research and development expenses for the cumulative consolidated period through the first quarter were ¥448 million.」

    The company additionally disclosed research and development expenses of ¥448 million for the cumulative consolidated period through the first quarter.
  13. FY2021AdvancedAnnual report

    「In research and development, the company places safety and security first and, in addition to pursuing taste, is developing products focused on convenience and environmental considerations in response to social demands such as rising demand for meals prepared at home, changes in household composition and working styles, and environmental issues. Through these efforts, it is creating new value, helping resolve social issues and contributing to environmental conservation. Research and development expenses for the consolidated fiscal year were ¥1,815 million.」

    The company expanded the scope of research and development to convenience, environmental considerations and responses to social issues, implementing new products, new materials and extended shelf lives across multiple businesses. Annual research and development expenses were ¥1,815 million.
  14. FY2021-Q3Addition of cumulative third-quarter research and development expensesAnnual report

    「Total research and development expenses for the cumulative consolidated period through the third quarter were ¥1,346 million.」

    The company additionally disclosed research and development expenses of ¥1,346 million for the cumulative consolidated period through the third quarter.
  15. FY2021-Q2Addition of cumulative second-quarter research and development expensesAnnual report

    「Total research and development expenses for the cumulative consolidated period through the second quarter were ¥893 million.」

    The company additionally disclosed research and development expenses of ¥893 million for the cumulative consolidated period through the second quarter.
  16. FY2021-Q1Addition of cumulative first-quarter research and development expensesAnnual report

    「Total research and development expenses for the three months ended the first quarter of the current consolidated fiscal year were ¥451 million.」

    The Group added disclosure of research and development expenses of ¥451 million for the cumulative first quarter.
  17. FY2020-Q3Addition of cumulative third-quarter research and development expensesAnnual report

    「Total research and development expenses for the nine months ended the third quarter of the current consolidated fiscal year were ¥1,420 million.」

    The Group added disclosure of research and development expenses of ¥1,420 million for the cumulative third quarter.
  18. FY2020-Q2Addition of cumulative second-quarter research and development expensesAnnual report

    「Total research and development expenses for the six months ended the second quarter of the current consolidated fiscal year were ¥945 million.」

    The Group added disclosure of research and development expenses of ¥945 million for the cumulative second quarter.
  19. FY2019AdvancedAnnual report

    「During the consolidated fiscal year, we established a comprehensive research institute adjacent to the Kanto Plant in Tatebayashi, Gunma Prefecture, relocating it from Koto Ward, Tokyo. Under the theme of “creating a new food culture,” the facility is strengthening research and development and quality assurance systems for the next medium-term management plan by bringing together the knowledge, experience, and technologies of diverse personnel in an enhanced facility and environment. Research and development expenses for the consolidated fiscal year were ¥1,869 million.」

    The comprehensive research institute was newly established and relocated, and efforts were made to enhance research and development and quality assurance systems. Product development addressing health orientation, convenience, and social issues was also made more specific.
  20. FY2017AdvancedAnnual report

    「In the overseas instant noodle business, we expanded our range of Asian-flavored products and reduced-sodium products in response to the growing interest in health in recent years.」

    The Group expanded its response to demand for high-quality, health-oriented products through Asian flavors, reduced-sodium products, and products with reduced salt or carbohydrates. Research and development expenses were ¥1,551 million.
  21. FY2016First statedAnnual report

    「Recent consumer trends indicate growing demand for highly differentiated, high-quality products. We are therefore focusing on developing such products, as well as products that address the growing interest in health.」

    High quality, health-conscious products and reduced-sodium products are priorities for research and development.
Moved together

"Improving Long-Selling Products and Creating New Food Culture" moved the same way as this thread, in the same document, in 7 of its 21 moves.

777555★123456
  1. ★This thread
  2. 1Improving Long-Selling Products and Creating New Food Culture7×
  3. 2Proactive Capital Investment in Growth Categories7×
  4. 3Strengthening Organizational and Human Resources Capabilities and Promoting Diversity7×
  5. 4Sustainable Growth in the United States and Mexico5×
  6. 5Environmental Initiatives and Corporate Social Responsibility5×
  7. 6Strategic Shareholdings to Strengthen Business Relationships5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Toyo Suisan's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Research and Development of High-Quality, Health-Oriented Products | TOYO SUISAN KAISHA,LTD. (2875) | Komori